A Waterlooville father who lost his wife to bowel cancer after living with colitis for more than half her life, has welcomed ...

The company is in the midst of a rebranding initiative, which will soon reflect its name change to IMAC Holdings, Inc., doing business as Ignite Sciences, Inc. This transition signals its sharpened ...

A pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and ...

A breakthrough new treatment Digoxin that is currently being tested successfully on rodents, promises tumour termination with ...

Triple-negative breast cancer (TNBC) has long been one of the most difficult forms of breast cancer to treat. Unlike other breast cancer subtypes, TNBC lacks ...

Limited to estrogen receptor-positive breast cancer (ER+) the compound addresses many common concerns with existing treatment ...

A pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and ...

An international team of doctors led by Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer ...

Researchers at the Terasaki Institute for Biomedical Innovation have developed an innovative delivery system that could significantly improve the effectiveness of peptide-based cancer vaccines, ...

(Image Credits: Pixabay) Breast cancer is the most common form of cancer in women across the world. Scientists have developed a new drug for ... in breast cancer treatment over the years.

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...

Companies also provide insights into proposed strategic mergerSAN MATEO, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Vincerx ...